Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 3
2011 1
2012 2
2013 3
2014 5
2015 4
2016 5
2017 7
2018 1
2019 1
2020 5
2021 8
2022 8
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ"
Page 1
Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis.
Bundred JR, Michael S, Stuart B, Cutress RI, Beckmann K, Holleczek B, Dahlstrom JE, Gath J, Dodwell D, Bundred NJ. Bundred JR, et al. BMJ. 2022 Sep 21;378:e070346. doi: 10.1136/bmj-2022-070346. BMJ. 2022. PMID: 36130770 Free PMC article.
OBJECTIVE: To determine if margin involvement is associated with distant recurrence and to determine the required margin to minimise both local recurrence and distant recurrence in early stage invasive breast cancer. DESIGN: Prospectively registered systematic revie …
OBJECTIVE: To determine if margin involvement is associated with distant recurrence and to determine the required margin to minimise both lo …
Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis.
Hussein H, Abbas E, Keshavarzi S, Fazelzad R, Bukhanov K, Kulkarni S, Au F, Ghai S, Alabousi A, Freitas V. Hussein H, et al. Radiology. 2023 Mar;306(3):e221785. doi: 10.1148/radiol.221785. Epub 2023 Jan 31. Radiology. 2023. PMID: 36719288
Background The best supplemental breast cancer screening modality in women at average risk or intermediate risk for breast cancer with dense breast and negative mammogram remains to be determined. ...Metaregression models showed that MRI was superior to other …
Background The best supplemental breast cancer screening modality in women at average risk or intermediate risk for breast can …
The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review.
Poelhekken K, Lin Y, Greuter MJW, van der Vegt B, Dorrius M, de Bock GH. Poelhekken K, et al. Breast. 2023 Oct;71:74-81. doi: 10.1016/j.breast.2023.07.012. Epub 2023 Jul 27. Breast. 2023. PMID: 37541171 Free PMC article. Review.
OBJECTIVE: Assumptions on the natural history of ductal carcinoma in situ (DCIS) are necessary to accurately model it and estimate overdiagnosis. ...The most important assumptions regarding the natural history of DCIS were addition of non-progressive DCIS of …
OBJECTIVE: Assumptions on the natural history of ductal carcinoma in situ (DCIS) are necessary to accurately model it a …
Patient-reported outcomes in ductal carcinoma in situ: A systematic review.
King MT, Winters ZE, Olivotto IA, Spillane AJ, Chua BH, Saunders C, Westenberg AH, Mann GB, Burnett P, Butow P, Rutherford C. King MT, et al. Eur J Cancer. 2017 Jan;71:95-108. doi: 10.1016/j.ejca.2016.09.035. Epub 2016 Dec 15. Eur J Cancer. 2017. PMID: 27987454 Review.
Ductal carcinoma in situ (DCIS) is a pre-invasive breast cancer with excellent prognosis but with potential adverse impacts of diagnosis and treatment on quality of life and other patient-reported outcomes (PROs). ...Evidence pooled across treat …
Ductal carcinoma in situ (DCIS) is a pre-invasive breast cancer with excellent prognosis but with potenti …
Post-operative radiotherapy for ductal carcinoma in situ of the breast.
Goodwin A, Parker S, Ghersi D, Wilcken N. Goodwin A, et al. Cochrane Database Syst Rev. 2013 Nov 21;(11):CD000563. doi: 10.1002/14651858.CD000563.pub7. Cochrane Database Syst Rev. 2013. PMID: 24259251 Review.
Ductal carcinoma in situ (DCIS) is a pre-invasive lesion. Recurrence of ipsilateral disease following BCS can be either DCIS or invasive breast cancer. ...Reference lists of articles and handsearching of ASCO (2007), ESMO (2002 to 2007), …
Ductal carcinoma in situ (DCIS) is a pre-invasive lesion. Recurrence of ipsilateral disease following BCS can be …
Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis.
Staley H, McCallum I, Bruce J. Staley H, et al. Breast. 2014 Oct;23(5):546-51. doi: 10.1016/j.breast.2014.06.015. Epub 2014 Jul 9. Breast. 2014. PMID: 25023044 Free article. Review.
This review aimed to assess the effects of postoperative Tamoxifen following surgical resection of ductal carcinoma in situ (DCIS). Data on local DCIS recurrence, new invasive carcinoma, distant disease, mortality and adverse effects were extrac …
This review aimed to assess the effects of postoperative Tamoxifen following surgical resection of ductal carcinoma in situ …
Partial breast irradiation versus whole breast radiotherapy for early breast cancer.
Hickey BE, Lehman M. Hickey BE, et al. Cochrane Database Syst Rev. 2021 Aug 30;8(8):CD007077. doi: 10.1002/14651858.CD007077.pub4. Cochrane Database Syst Rev. 2021. PMID: 34459500 Free PMC article. Review.
BACKGROUND: Breast-conserving therapy for women with breast cancer consists of local excision of the tumour (achieving clear margins) followed by radiotherapy (RT). ...MAIN RESULTS: We included nine RCTs that enrolled 15,187 women who had invasive breast …
BACKGROUND: Breast-conserving therapy for women with breast cancer consists of local excision of the tumour (achieving clear m …
Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review.
Schiller-Frühwirth IC, Jahn B, Arvandi M, Siebert U. Schiller-Frühwirth IC, et al. Appl Health Econ Health Policy. 2017 Jun;15(3):333-351. doi: 10.1007/s40258-017-0312-3. Appl Health Econ Health Policy. 2017. PMID: 28185134 Review.
The models employed different assumptions regarding ductal carcinoma in situ. Thirteen studies performed cost-utility analyses with different sources for utility values, but assumptions were often made about utility weights. ...CONCLUSION: State-transition mo …
The models employed different assumptions regarding ductal carcinoma in situ. Thirteen studies performed cost-utility a …
Postoperative tamoxifen for ductal carcinoma in situ.
Staley H, McCallum I, Bruce J. Staley H, et al. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007847. doi: 10.1002/14651858.CD007847.pub2. Cochrane Database Syst Rev. 2012. PMID: 23076938 Review.
BACKGROUND: Ductal carcinoma in situ (DCIS) is a non-invasive carcinoma of the breast. ...The treatment of DCIS tumours involves surgery with or without radiotherapy to prevent recurrent DCIS and invasive carcinoma. However, …
BACKGROUND: Ductal carcinoma in situ (DCIS) is a non-invasive carcinoma of the breast. ...The trea …
Post-operative radiotherapy for ductal carcinoma in situ of the breast.
Goodwin A, Parker S, Ghersi D, Wilcken N. Goodwin A, et al. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000563. doi: 10.1002/14651858.CD000563.pub6. Cochrane Database Syst Rev. 2009. PMID: 19821272 Updated. Review.
Ductal carcinoma in situ (DCIS) is a pre-invasive lesion. Recurrence of ipsilateral disease following BCS can be either DCIS or invasive breast cancer. ...Reference lists of articles and handsearching of ASCO (2007), ESMO (2002 to 2007), …
Ductal carcinoma in situ (DCIS) is a pre-invasive lesion. Recurrence of ipsilateral disease following BCS can be …
61 results